Gynecologic and Breast Pathology Fellowship

Applicants must have an M.D. or D.O. degree (or foreign equivalent with ECFMG certification) and be board eligible or certified in anatomic or anatomic and clinical pathology.

Number of positions: 1

Position Filled for 2025 – 2026

Position Filled for 2026 – 2027

Position for 2027 – 2028 – Accepting applications 

The UVA Department of Pathology provides an extensive training resources for our Gynecologic and Breast pathology fellows.  This includes annual accessions of over 40,000 in-house surgical pathology specimens, more than 8,000 of which are in the areas of gynecologic and breast pathology, as well as robust extramural consults in gynecologic and breast pathology. Our excellent intradepartmental laboratories offer a full suite of ancillary testing with extensive immunohistochemistry (including assays relevant to cutting-edge gynecologic tumor work-ups such as PD-L1, MMR, pan-TRK, BRG1, and BCOR), high and low-risk HPV RNA in situ hybridization, HER2 testing by both IHC and chromogenic ISH, a 500+ somatic tumor sequencing gene panel that includes POLE.  Additionally, our biorepository and tissue research facility provides all the necessary support for research productivity, including tissue microarray construction and multicolor immunohistochemistry capabilities.

Stipend commensurate with the applicant’s postgraduate training in pathology.

We are accepting applications for the 2027 – 2028 academic year. Interview and offer timeline details are forthcoming.

To apply, send the CAP common application form (https://www.cap.org/member-resources/residents), current CV, 3 letters of recommendation (addressed to the program director), personal statement, medical school transcript, and a copy of your USMLE transcript to:

Tonya Test
Medical Education Coordinator
Department of Pathology
University of Virginia
tmt4f@uvahealth.org

Anne Mills, M.D., AP/CP Residency Program Director, Gynecologic and Breast Pathology Fellowship Program Director

Kristen Atkins, M.D., Director of Anatomic Pathology

Mick Crawford, M.D., Digital Pathology Director

Ed Stelow, M.D., Cytopathology Fellowship Program Director

The UVA Pathology Gynecologic and Breast Pathology fellows actively engage in scholarly activities, including research studies, chapters, and review articles.  For fellows planning to pursue a career in academics, we make sure to have research opportunities at the ready when the fellow arrives so that they can hit the ground running.  For those more interested in practicing in a community setting, we focus on quality and leadership experiences and practical review articles to best prepare them for life in practice and build their diagnostic expertise.  For those interested in conducting research, they may elect to spearhead studies as first authors, or to serve as collaborator with colleagues both within and beyond our department… or a bit of both! In addition to presenting their work at conferences such as the Annual Meetings of the United States and Canadian Academy of Pathology and the College of American Pathologists, our fellows do an excellent job seeing their work through to publication. Below are examples of first-author publications from current, future, and prior UVA Gyn and Breast Pathology Fellows:

• EM Alzayadneh, V Smith, AM Mills. Endometrial Carcinoma of Gastrointestinal-type (EMCG):Incidence, Molecular Features, and Distinction from Other Endometrial Cancers with Gastrointestinal Marker Immunoexpression. 2025 Submitted
• DK Carlson (incoming fellow), C Painter, KL Ring, ES Williams, AM Mills. High-grade endometrial carcinomas with solid basaloid morphology and geographic necrosis lacking definitive pilomatrix-like features: Clinicopathologic characteristics including aggressive behavior and novel molecular events. Int J Gyn Pathol 2025 1;44(3):199-209
• L Griesinger, A Nyarko-Odoom, SA Martinez, N She, K Ring, E Gaughan, A Mills. PD-L1 and MHC Class I expression in high-grade ovarian cancers, including platinum-resistant recurrences treated with checkpoint inhibitor therapy. Appl Immunohistochem Mol Morphol 2023. 31(4);197-203.
• JD Coppock, SE Gradecki, AM Mills. PRAME Expression in Endometrioid and Serous Endometrial Carcinoma: A Possible Diagnostic Pitfall and Potential Immunotherapeutic Target. Int J Gynecol Pathol 2023;43(1):35-42.
• TM Jenkins, LA Cantrell, MH Stoler, AM Mills. HER2 overexpression and amplification in uterine carcinosarcomas with serous morphology. Am J Surg Pathol 2022; 45(4): 435-442.
• TM Jenkins, LA Cantrell, MH Stoler, AM Mills. PD-L1 and mismatch repair status in uterine carcinosarcoma. Int J Gynecol Pathol 2021; 40(6):563-574.
• M Crawford, TM Jenkins, AM Mills. “Cervical Squamous Carcinoma.” Atlas of Diagnostic Pathology of the Cervix: A Case-Based Approach. 1^st edition. Springer. 2021
• ME Dibbern, TN Bullock, TM Jenkins, LR Duska, MH Stoler, AM Mills. Loss of MHC class I expression in HPV-associated cervical and vulvar neoplasia: A potential mechanism of resistance to checkpoint inhibition. Am J Surg Pathol 2020; 44(9):1184-1191.
• TM Jenkins, KZ Hanley, LE Schwartz, L Cantrell, MH Stoler, AM Mills. Mismatch repair deficiency in uterine carcinosarcoma: A multi-institutional retrospective review. Am J Surg Pathol 2020; 44(6):782-792.
• ED Shanes, LA Friedman, AM Mills. PD-L1 expression and tumor-infiltrating lymphocytes in uterine smooth muscle tumors: Implications for immunotherapy. Am J Surg Pathol. 2019; 43(6):792-801.
• JD Coppock, AK Volaric, AM Mills, AA Gru. Concordance levels of PD-L1 expression by immunohistochemistry mRNA in situ hybridization, and outcome in lung carcinomas. Human Pathol 2018; 82:282-288.
• JD Coppock, B Willis, M Stoler, AM Mills. HPV RNA in situ hybridization can inform cervical cytology-histology correlation. Cancer Cytopathol 2018; 126(8):533-540.
• Z Chinn, Stoler MH, AM Mills. PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: Implications for combination immunotherapy. Histopathology 2019; 74(2):256-268.
• B Willis, EA Sloan, KA Atkins, MH Stoler, AM Mills. Mismatch repair status and PD-L1 Expression in Ovarian and Endometrial Clear Cell Carcinomas. Mod Pathol 2017; 30(11):1622-1632.

And here are a few examples of projects where fellows served as key collaborators on original research and high-profile chapters:

• AM Mills, EM Alzayadneh, Wenxin Zheng. “Molecular Classification of Endometrial Carcinoma and its Clinical Applications.” Gynecologic and Obstetric pathology. Ed. Z Wenxin, CM Quick, O Fadare. London: Springer Press. 2024.
• YS Park, M Dibbern, AM Mills. Cervical Pap Cytology in Endometrial Cancer Patients with Lynch Syndrome: Opportunities for Early Detection and Limitations. Journal of the American Society of Cytopathology 2024 12(6):4380443.
• AM Mills, ME Dibbern, TA Jenkins, KA Atkins, KL Ring. Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors versus Carcinomas with Non-Specific Expression of Yolk Sac Markers. Am J Surg Pathol 2024 48(7):790-802.
• Meneveau MO, Crawford MP, Turkeimer LM, Millard TA, Atkins KA, Showalter SL. The POWER-PAK Score Characterizes Tumor Response to 3 Months of Preoperative Endocrine Therapy. Ann Surg Oncol 2023 Oct;30(10):6034-6040.
• AM Mills, TM Jenkins, BE Howitt, J Fan, KL Ring, I Cook.  Immunohistochemical Screening for Mesonephric-like Endometrial Carcinoma: Morphologic and Molecular Features of Screen-Positive Cases.  2022 Am J Surg Pathol 46(7):921-932.

The UVA Pathology Gynecologic and Breast Pathology fellows go on to pursue fulfilling careers in both academics and private practice.  Below you can see examples of where our recent trainees have landed: